Uric acid levels and vascular disease.
作者： S. S. Daskalopoulou , V. G. Athyros , M. Elisaf , D. P. Mikhailidis
DOI: 10.1185/030079904125003971
关键词:
摘要: SUMMARYThere is evidence showing that serum uric acid (SUA) levels predict the risk for vascular events. For example, up to 29% of reduction in primary composite endpoint seen LIFE trial (favouring losartan versus atenolol) can be attributed a fall SUA levels. We also discuss findings GREACE study (treating target with atorvastatin ‘usual’ care) relation In this brief comment we extend argument consider SUA-lowering effect other drugs commonly prescribed patients disease (e.g. statins, fibrates and antihypertensive agents).
informahealthcare.com参考文章(46)
Targher G, Zenere Mb, Branzi P, Saggiani F, Travia D, Bonora E, Zenti Mg, Muggeo M, Santi L, Tosi F, Cacciatori, Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. International Journal of Obesity. ,vol. 20, pp. 975- 980 ,(1996)
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet. ,vol. 361, pp. 2005- 2016 ,(2003) , 10.1016/S0140-6736(03)13636-7
C. Kilo, J. Dudley, B. Kalb, Evaluation of the efficacy and safety of Diamicron in non-insulin-dependent diabetic patients. Diabetes Research and Clinical Practice. ,vol. 14, ,(1991) , 10.1016/0168-8227(91)90012-3
Lars H Lindholm, Hans Ibsen, Knut Borch-Johnsen, Michael Hecht Olsen, Kristian Wachtell, Björn Dahlöf, Richard B Devereux, Gareth Beevers, Ulf de Faire, Frej Fyhrquist, Stevo Julius, Sverre E Kjeldsen, Krister Kristianson, Ole Lederballe-Pedersen, Markku S Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan M Edelman, Steven Snapinn, LIFE Study Group, None, Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension. ,vol. 20, pp. 1879- 1886 ,(2002) , 10.1097/00004872-200209000-00035
CALLE BENGTSSON, LEIF LAPIDUS, CHARLOTTE STENDAHL, JOHAN WALDENSTRÖM, Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Medica Scandinavica. ,vol. 224, pp. 549- 555 ,(2009) , 10.1111/J.0954-6820.1988.TB19625.X
VG Athyros, DP Mikhailidis, AA Papageorgiou, AN Symeonidis, AN Pehlivanidis, VI Bouloukos, M Elisaf, The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study Journal of Clinical Pathology. ,vol. 57, pp. 728- 734 ,(2004) , 10.1136/JCP.2003.012989
Vasilios G Athyros, Athanasios A Papageorgiou, Moses Elisaf, Dimitri P Mikhailidis, GREACE Study Collaborative Group, None, Statins and renal function in patients with diabetes mellitus Current Medical Research and Opinion. ,vol. 19, pp. 615- 617 ,(2003) , 10.1185/030079903125002315
Gianni Minghelli, Charles Seydoux, Jean-Jacques Goy, Michel Burnier, Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients. Transplantation. ,vol. 66, pp. 268- 271 ,(1998) , 10.1097/00007890-199807270-00023
Caroline S Fox, Martin G Larson, Eric P Leip, Bruce Culleton, Peter WF Wilson, Daniel Levy, Predictors of New-Onset Kidney Disease in a Community-Based Population JAMA. ,vol. 291, pp. 844- 850 ,(2004) , 10.1001/JAMA.291.7.844
M. A. BARRADAS, D. S. GILL, V. A. FONSECA, D. P. MIKHAILIDIS, P. DANDONA, Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease European Journal of Clinical Investigation. ,vol. 18, pp. 399- 404 ,(1988) , 10.1111/J.1365-2362.1988.TB01030.X